LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Employment & Personnel Businesses for Sale
Warehouse & Storage Businesses for Sale
Gift & Flower Shops for Sale
Real Estate & Property Management Companies for Sale
Bars, Pubs & Nightclubs for Sale
Vending & Kiosk Businesses for Sale
Automotive Businesses for Sale
Coin Laundry & Dry Cleaning Businesses for Sale
Beauty & Personal Care Businesses for Sale
Transport & Shipping Businesses for Sale
Finance & Accounting Franchise Opportunities
Beauty & Personal Care Franchises for Sale
Furniture & Home Decor Franchise Opportunities
Home Based Franchise Opportunities
Vending & Kiosk Franchises for Sale
Restaurant Franchises for Sale
Convenience Store & Lotto Franchises for Sale
Hotel & Motel Franchises for Sale
Consultancy & Training Franchise Opportunities
Employment & Personnel Franchise Opportunities
Apartment Buildings for Sale
Plazas for Sale
Office Spaces for Sale or Rent
Retail Buildings for Sale or Lease
Places of Worship for Sale
Land & Developments for Sale
Industrial Buildings for Sale or Lease
Retail Spaces for Lease or Sale
Houses & Condos for Sale or Lease
Office Buildings for Sale or Rent
An email will be sent to registered email address.
Please select if you are: